Systemic Sclerosis (SSc) is an autoimmune disease marked by dysregulation of the immune
system, tissue fibrosis and dysfunction of the vasculature. Vascular damage, remodeling and …

Sarcopenia is a progressive loss of muscle mass and strength with a risk of adverse
outcomes such as disability, poor quality of life, and death. Increasing evidence indicates …

Objective To describe systemic sclerosis (SSc) with myopathy in patients without classic SSc-
specific and SSc-overlap autoantibodies (aAbs), referred to as seronegative scleromyositis …

Hypertrophic scarring is a skin collagen disease that can occur following skin damage and is
unlikely to heal or subside naturally. Since surgical treatment often worsens scarring, it is …

The latest results obtained from the study of long cohorts of patients with various
neuromuscular diseases open the door to the use of this technology in clinical trials, which …

Abstract Purpose of Review Systemic sclerosis (SSc) and myositis are two different entities
that may coexist as an overlap syndrome. Immunological biomarkers such as anti-PM/Scl or …

We performed a systematic review of the clinical manifestations and complementary exams
of patients with myopathies and systemic sclerosis overlap syndrome (MyoSScOS) …

The relationship of ADAMTS (a disintegrin and metalloproteinase with thrombospondin
motifs) proteases with inflammatory processes was anticipated since their discovery …

Excessive accumulation of intermuscular adipose tissue (IMAT) is a common pathological
feature in various metabolic and health conditions and can cause muscle atrophy, reduced …

Systemic sclerosis (SSc) is a rare systemic autoimmune disease of unknown etiology, which
is characterized by endothelial dysfunction, pathologic vasculopathy, and increased tissue …